Aflac IncorporatedAFL
▼ NegativeCapitalrelevance
Q2 revenue missed estimates and declined 9.2% YoY, though EPS met consensus.

Aflac reported second-quarter revenue of $4.12 billion, missing analyst estimates of $4.23 billion and marking a 9.2% year-on-year decline. Adjusted earnings per share came in at $1.75, in line with the consensus estimate of $1.76. Book value per share rose 18.7% year on year to $60.35, beating expectations of $55.23. Chairman and CEO Daniel P. Amos highlighted solid earnings and strategic execution, including new product initiatives in Japan and a focus on supplemental health products in the U.S. The stock fell 1.4% to $124.92 following the release.
Aflac IncorporatedQ2 revenue missed estimates and declined 9.2% YoY, though EPS met consensus.